Hem Pandya is an experienced pharmaceutical executive with a broad spectrum of commercial, operational, strategic and corporate development experience. Previously, Mr. Pandya was President and Chief Executive Officer of IGI Laboratories Inc. (NYSE AMEX: IG) a provider of topical formulation development, analytical, manufacturing and packaging services to the pharmaceutical industry. Prior to IGI, Mr. Pandya was Chief Operating Officer of NexMed Inc. (NASDAQ : NEXM) responsible for R&D, Operations, and Corporate Development. He has also served in various senior management roles within the pharmaceutical industry including Senior Vice President of Business Development and Strategic Alliances for Andrx Pharmaceuticals (now Watson), Vice President of Corporate Development and Commercial Operations for Able Laboratories, Inc. and senior management roles with Ivax Pharmaceuticals, Inc. (now Teva) and Faulding/Purepac Pharmaceutical Company (subsequently Alpharma, Inc.).